BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33928988)

  • 1. A target-triggered and self-calibration aptasensor based on SERS for precise detection of a prostate cancer biomarker in human blood.
    Wu Q; Chen G; Qiu S; Feng S; Lin D
    Nanoscale; 2021 Apr; 13(16):7574-7582. PubMed ID: 33928988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of prostate cancer biomarkers via a SERS-based aptasensor.
    Zhao J; Wang J; Liu Y; Han XX; Xu B; Ozaki Y; Zhao B
    Biosens Bioelectron; 2022 Nov; 216():114660. PubMed ID: 36099835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a sensitive and selective plasmonic biosensor for prostate specific antigen by combining magnetic molecularly-imprinted polymer and surface-enhanced Raman spectroscopy.
    Turan E; Zengin A; Suludere Z; Kalkan NÖ; Tamer U
    Talanta; 2022 Jan; 237():122926. PubMed ID: 34736663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vertical flow assays based on core-shell SERS nanotags for multiplex prostate cancer biomarker detection.
    Chen R; Liu B; Ni H; Chang N; Luan C; Ge Q; Dong J; Zhao X
    Analyst; 2019 Jul; 144(13):4051-4059. PubMed ID: 31157328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel label-free colorimetric aptasensor for sensitive determination of PSA biomarker using gold nanoparticles and a cationic polymer in human serum.
    Shayesteh OH; Ghavami R
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 226():117644. PubMed ID: 31614271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
    Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
    Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrochemical bioassay development for ultrasensitive aptasensing of prostate specific antigen.
    Heydari-Bafrooei E; Shamszadeh NS
    Biosens Bioelectron; 2017 May; 91():284-292. PubMed ID: 28033557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel SERS-based magnetic aptasensor for prostate specific antigen assay with high sensitivity.
    Yang K; Hu Y; Dong N; Zhu G; Zhu T; Jiang N
    Biosens Bioelectron; 2017 Aug; 94():286-291. PubMed ID: 28292735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous immunoassays of dual prostate cancer markers using a SERS-based microdroplet channel.
    Gao R; Cheng Z; Wang X; Yu L; Guo Z; Zhao G; Choo J
    Biosens Bioelectron; 2018 Nov; 119():126-133. PubMed ID: 30121424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SERS-Based Pump-Free Microfluidic Chip for Highly Sensitive Immunoassay of Prostate-Specific Antigen Biomarkers.
    Gao R; Lv Z; Mao Y; Yu L; Bi X; Xu S; Cui J; Wu Y
    ACS Sens; 2019 Apr; 4(4):938-943. PubMed ID: 30864786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous detection of dual biomarkers using hierarchical MoS
    Yan R; Lu N; Han S; Lu Z; Xiao Y; Zhao Z; Zhang M
    Biosens Bioelectron; 2022 Feb; 197():113797. PubMed ID: 34818600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and sensitive detection of prostate-specific antigen via label-free frequency shift Raman of sensing graphene.
    Liu S; Huo Y; Bai J; Ning B; Peng Y; Li S; Han D; Kang W; Gao Z
    Biosens Bioelectron; 2020 Jun; 158():112184. PubMed ID: 32275212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SERS-based biosensor for detection of f-PSA%: Implications for the diagnosis of prostate cancer.
    Zhao J; Ma H; Liu Y; Xu B; Song L; Han X; Liu R; He C; Cheng Z; Zhao B
    Talanta; 2023 Aug; 261():124654. PubMed ID: 37196403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilely self-assembled and dual-molecule calibration aptasensor based on SERS for ultra-sensitive detection of tetrodotoxin in pufferfish.
    Yin L; Fan M; She Q; You R; Lu Y; Lu D; Li M
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Oct; 279():121275. PubMed ID: 35605417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Detection of Dual Prostate Specific Antigens Using Surface-Enhanced Raman Scattering-Based Immunoassay for Accurate Diagnosis of Prostate Cancer.
    Cheng Z; Choi N; Wang R; Lee S; Moon KC; Yoon SY; Chen L; Choo J
    ACS Nano; 2017 May; 11(5):4926-4933. PubMed ID: 28441008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graphene oxide layer decorated gold nanoparticles based immunosensor for the detection of prostate cancer risk factor.
    Pal M; Khan R
    Anal Biochem; 2017 Nov; 536():51-58. PubMed ID: 28789963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunosensing device based on inhibition of mediator's faradaic process for early diagnosis of prostate cancer using bifunctional nanoplatform reinforced by carbon nanotube.
    Farzin L; Sadjadi S; Shamsipur M; Sheibani S
    J Pharm Biomed Anal; 2019 Aug; 172():259-267. PubMed ID: 31078062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the Ratio of Two Types of Prostate Specific Antigens with Biochips and Gold Nanoparticles for Accurate Prostate Cancer Diagnosis.
    Yoo M; Yeo WS
    Anal Sci; 2016; 32(10):1117-1121. PubMed ID: 27725614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Label-free determination of prostate specific membrane antigen in human whole blood at nanomolar levels by magnetically assisted surface enhanced Raman spectroscopy.
    Chaloupková Z; Balzerová A; Bařinková J; Medříková Z; Šácha P; Beneš P; Ranc V; Konvalinka J; Zbořil R
    Anal Chim Acta; 2018 Jan; 997():44-51. PubMed ID: 29149993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal-on electrochemical aptasensors with different target-induced conformations for prostate specific antigen detection.
    Zhao B; Miao P; Hu Z; Zhang X; Geng X; Chen Y; Feng L
    Anal Chim Acta; 2021 Apr; 1152():338282. PubMed ID: 33648646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.